These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28927061)

  • 1. 5FU resistance caused by reduced fluoro-deoxyuridine monophosphate and its reversal using deoxyuridine.
    Mori R; Futamura M; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K; Yoshida K
    Oncol Lett; 2017 Sep; 14(3):3162-3168. PubMed ID: 28927061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.
    Mori R; Yoshida K; Futamura M; Suetsugu T; Shizu K; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K
    Gastric Cancer; 2019 May; 22(3):497-505. PubMed ID: 30276573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
    Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
    Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression.
    Matsuoka K; Nakagawa F; Kobunai T; Takechi T
    Oncotarget; 2018 Mar; 9(17):13438-13450. PubMed ID: 29568368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.
    Mori R; Ukai J; Tokumaru Y; Niwa Y; Futamura M
    Oncol Lett; 2022 Sep; 24(3):311. PubMed ID: 35949616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
    Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
    Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells.
    Mori R; Yoshida K; Tanahashi T; Yawata K; Kato J; Okumura N; Tsutani Y; Okada M; Oue N; Yasui W
    Gastric Cancer; 2013 Jul; 16(3):345-54. PubMed ID: 22968820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line.
    Tsutani Y; Yoshida K; Sanada Y; Wada Y; Konishi K; Fukushima M; Okada M
    Oncol Rep; 2008 Dec; 20(6):1545-51. PubMed ID: 19020740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes.
    Liao ZY; Sordet O; Zhang HL; Kohlhagen G; Antony S; Gmeiner WH; Pommier Y
    Cancer Res; 2005 Jun; 65(11):4844-51. PubMed ID: 15930305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, characterization and application of an antibody against 5-fluoro-2'deoxyuridine-5'monophosphate, the active metabolite of 5-fluorouracil.
    Peters GJ; Laurensse E; Steinbusch HW; De Vente J; Smid K; Van der Wilt CL; Pinedo HM
    Anticancer Res; 1993; 13(4):835-9. PubMed ID: 8352551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.
    Inaba M; Mitsuhashi J; Sawada H; Miike N; Naoe Y; Daimon A; Koizumi K; Tsujimoto H; Fukushima M
    Jpn J Cancer Res; 1996 Feb; 87(2):212-20. PubMed ID: 8609072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
    Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological quantitation of thymidylate synthase-FdUMP-5,10-methylenetetrahydrofolate ternary complex with the monoclonal antibody TS 106.
    Drake JC; Allegra CJ; Johnston PG
    Anticancer Drugs; 1993 Aug; 4(4):431-5. PubMed ID: 8400344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorouracil: biochemistry and pharmacology.
    Pinedo HM; Peters GF
    J Clin Oncol; 1988 Oct; 6(10):1653-64. PubMed ID: 3049954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of 5-fluorodeoxyuridine monophosphate-thymidylate synthase ternary complex levels by autophagy confers resistance to 5-fluorouracil.
    Nishizawa N; Kurasaka C; Ogino Y; Sato A
    FASEB Bioadv; 2023 Jan; 5(1):43-51. PubMed ID: 36643896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for the determination of total, free, and 5-fluorodeoxyuridylate-bound thymidylate synthase in cell extracts.
    Fernandes DJ; Cranford SK
    Anal Biochem; 1984 Nov; 142(2):378-85. PubMed ID: 6241433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of modified siRNA molecules incorporating 5-fluoro-2'-deoxyuridine residues to enhance cytotoxicity.
    Wu SY; Chen TM; Gmeiner WH; Chu E; Schmitz JC
    Nucleic Acids Res; 2013 Apr; 41(8):4650-9. PubMed ID: 23449220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.
    Erlichman C; Mitrovski B
    Cancer Chemother Pharmacol; 1994; 34(1):51-6. PubMed ID: 8174202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.